Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Inventory (2016 - 2025)

Collegium Pharmaceutical has reported Inventory over the past 10 years, most recently at $40.9 million for Q4 2025.

  • Quarterly results put Inventory at $40.9 million for Q4 2025, up 15.05% from a year ago — trailing twelve months through Dec 2025 was $40.9 million (up 15.05% YoY), and the annual figure for FY2025 was $40.9 million, up 15.05%.
  • Inventory for Q4 2025 was $40.9 million at Collegium Pharmaceutical, up from $38.1 million in the prior quarter.
  • Over the last five years, Inventory for COLL hit a ceiling of $80.1 million in Q1 2022 and a floor of $15.5 million in Q1 2021.
  • Median Inventory over the past 5 years was $34.8 million (2023), compared with a mean of $37.6 million.
  • Biggest five-year swings in Inventory: soared 417.14% in 2022 and later plummeted 66.53% in 2023.
  • Collegium Pharmaceutical's Inventory stood at $17.4 million in 2021, then soared by 167.34% to $46.5 million in 2022, then tumbled by 30.47% to $32.3 million in 2023, then rose by 9.98% to $35.6 million in 2024, then rose by 15.05% to $40.9 million in 2025.
  • The last three reported values for Inventory were $40.9 million (Q4 2025), $38.1 million (Q3 2025), and $38.1 million (Q2 2025) per Business Quant data.